天壇生物(600161.SH)所屬企業擬實施捐贈
格隆匯 12 月 4日丨天壇生物(600161.SH)公佈,公司召開第八屆董事會第四次會議,審議通過《關於所屬企業實施捐贈的議案》。
同意公司所屬國藥集團上海血液製品有限公司(“上海血制”)向雲南省温暖工程慈善基金會捐贈30萬元;同意上海血制向雲南省紅十字會捐贈42萬元;同意公司所屬國藥集團武漢血液製品有限公司武穴武源單採血漿有限公司向中國國家博物館捐贈1台血漿採集機(賬面淨值2.92萬元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.